Current Opinion in Lipidology
- Emerging insight into the role of cellular cholesterol in the pathogenesis of nonalcoholic steatohepatitis progression
- The potential role of the lipid phosphate phosphatase 3 (Plpp3) gene in cardiovascular disease
- Dietary patterns to promote healthy aging
- When to lower triglycerides?
- Metabolic and cardiovascular outcomes of bariatric surgery
- Dietary treatment to lower cholesterol and triglyceride and reduce cardiovascular risk
- Genetic, biochemical, and clinical features of LCAT deficiency: update for 2020
- Apolipoprotein F: a natural inhibitor of cholesteryl ester transfer protein and a key regulator of lipoprotein metabolism
- Epigenetics of paraoxonases
- Can genetic testing help in the management of dyslipidaemias?
- Small interfering RNA to proprotein convertase subtilisin/kexin type 9: transforming LDL-cholesterol-lowering strategies
- Evidence for improved survival with treatment of homozygous familial hypercholesterolemia
- Non-HDL or LDL cholesterol in heterozygous familial hypercholesterolaemia: findings of the Simon Broome Register
- Editorial introduction
- Metabolism of lipoprotein(a): new findings, implications and outstanding issues
- Regulation of lipoprotein lipase-mediated lipolysis of triglycerides
- The LDL cholesterol in stroke limbo: how low can we go?
- The next generation of triglyceride-lowering drugs: will reducing apolipoprotein C-III or angiopoietin like protein 3 reduce cardiovascular disease?
- Apolipoprotein C-II: the re-emergence of a forgotten factor
- Remnant lipoproteins: are they equal to or more atherogenic than LDL?